Led by Eli Lilly’s GLP-1 success, Humana’s expanding margins, and DexCom’s medtech growth, the healthcare sector is staging a major market rebound.
2 High-Flying Stocks to Target This Week and 1 Facing Challenges
Humana Inc. (NYSE: HUM) has been selected by the Illinois Department of Healthcare and Family Services (HFS) to serve members statewide in HealthChoice Illinois, the state’s Medicaid managed care program....
Humana and its health care services business, CenterWell , announce the inaugural Resident Physician Scholarship Program recipients. In partnership with the National Hispanic Medical...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti , LLC (“KSF”), announces that KSF continues its investigation into ...
Humana Inc. (NYSE: HUM) today announced that it has signed a definitive agreement with a consortium of investors to divest all or substantially all of its minority interest in Gentiva, the nation’s leading...
Humana Foundation’s Annual Double Match Day raises funds and surprises three lucky employees with a total of $45,000 in grants for nonprofits
As Centene has notably outperformed the Dow recently, analysts remain moderately optimistic about the stock’s prospects.
/Humana%20Inc_%20logo%20on%20building-by%20BalkansCat%20via%20iStock.jpg)
Humana has rallied the Nasdaq Composite over the past year, and analysts remain moderately bullish about the stock’s outlook.